Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leopold II: Kovaltry Prophylaxis vs On-demand in Hemophilia A
NCT01233258Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 18
01
Overview
A Phase 3 trial of damoctocog alfa pegol in hemophilia A, sponsored by Bayer. Started Jan 2011; status: completed.
02
Drugs
damoctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01233258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01233258.